Results 21 to 30 of about 65 (64)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment. [PDF]

open access: yesPLoS One, 2023
Shin HJ   +9 more
europepmc   +1 more source

An exploratory survey about using ChatGPT in education, healthcare, and research. [PDF]

open access: yesPLoS One, 2023
Hosseini M   +8 more
europepmc   +1 more source

Obscurin Rho GEF domains are phosphorylated by MST-family kinases but do not exhibit nucleotide exchange factor activity towards Rho GTPases in vitro. [PDF]

open access: yesPLoS One, 2023
Koch D   +8 more
europepmc   +1 more source

Combining DNA and HPTLC profiles to differentiate a pain relief herb, Mallotus repandus, from plants sharing the same common name, "Kho-Khlan". [PDF]

open access: yesPLoS One, 2022
Thongkhao K   +5 more
europepmc   +1 more source

Impact of measured versus estimated glomerular filtration rate-based screening on living kidney donor characteristics: A study of multiple cohorts. [PDF]

open access: yesPLoS One, 2022
van der Weijden J   +11 more
europepmc   +1 more source

Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study. [PDF]

open access: yesPLoS One, 2022
Na YO   +13 more
europepmc   +1 more source

Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand. [PDF]

open access: yesPLoS One, 2023
Pratedrat P   +12 more
europepmc   +1 more source

Liver injury in hospitalized patients with COVID-19: An International observational cohort study. [PDF]

open access: yesPLoS One, 2023
Tirupakuzhi Vijayaraghavan BK   +15 more
europepmc   +1 more source

Few SARS-CoV-2 infections detected in Newfoundland and Labrador in the absence of Public Health Laboratory-based confirmation. [PDF]

open access: yesPLoS One, 2022
Ings DP   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy